SARS-CoV-2 appears to downregulate the expression of ACE-2 on peripheral blood monocytes which show an activated phenotype in COVID-19 evidenced by morphology and IL-6, IL-10, and TNF-α production (31, 42, 43). The gene discussed is ACE2; the disease is COVID-19.